DSpace Repository
La recherche des agglutinine Irrégulières Chez Les Polytransfusés En Pédiatrie (panel restreint)
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Bordja, Dikra wafa | |
| dc.contributor.author | Boucebssi, Warda | |
| dc.contributor.author | Chekiel, Meriem | |
| dc.contributor.author | Hannachi, kenza | |
| dc.contributor.author | Encadré par : Dr. l Houar | |
| dc.date.accessioned | 2023-03-30T12:06:38Z | |
| dc.date.available | 2023-03-30T12:06:38Z | |
| dc.date.issued | 2018 | |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/2757 | |
| dc.description | MPH18/024 | en_US |
| dc.description.abstract | Abstract :Blood transfusion is the treatment of choice for hemoglobinopaths and cancerous. . -The search fminegularagglufininsisamrymwdeoectandidmüfyanfibodieswthe anti-erythrocyte antigens. -This technique helps to ensure transfusion safety in regularly transfused patient. -According to our results, the hemoglobinopaths represent 65% whereas the cancerous 35%. - Our study showed that the number of transfusions, the transfusion rate and the type of PSL favor a positive RAL -RAÏ was 100% negative, which is favored by the type of transfusion reactions (chills, hyperthermia, allergy). -In conclusion, transfusion safcty and hemovigilance require that RAI be performed prior to transfusion. | en_US |
| dc.language.iso | fr | en_US |
| dc.publisher | Université Constantine 3 Salah Boubnider,Faculté de Médecine | en_US |
| dc.subject | Les polytransfusés | en_US |
| dc.subject | Hémoglobinopathies | en_US |
| dc.subject | Oncologie | en_US |
| dc.subject | RALallo-anticorps anti-érythrocytaire | en_US |
| dc.subject | Test de coombs indirect | en_US |
| dc.subject | Abstract | en_US |
| dc.title | La recherche des agglutinine Irrégulières Chez Les Polytransfusés En Pédiatrie (panel restreint) | en_US |
| dc.type | Other | en_US |
